Vardenafil hydrochloride trihydrate - CAS# 330808-88-3 Catalog No.:M7032-2 Chelerythrine treatment inhibits LPS-induced TNF-α

Chelerythrine treatment inhibits LPS-induced TNF-α level and NO production in LPS-induced murine peritoneal macrophages through selective inhibition of p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) activation

SB-3CT has shown efficacy in an animal model of severe traumatic brain injury (TBI)

InChiKey: BQJRUJTZSGYBEZ-YVQNUNKESA-N

2ClH/c20-14-8-6-13(7-9-14)17-18(16-10-11-22-19(21)24-16)25(12-23-17)15-4-2-1-3-5-15

Smiles: CC1C=NC(=CC=1)C1C=CC(C)=CN=1

Vardenafil hydrochloride trihydrate - CAS# 330808-88-3 Catalog No.:M7032-2 Chelerythrine treatment inhibits LPS-induced TNF-αVardenafil hydrochloride trihydrate, CAS No. 330808 88 3, also known as BAY 38 9456, is a PDE5 inhibitor used for treating erectile dysfunction. Vardenafil's indications and contra indications are the same as with other PDE5 inhibitors; it is closely related in function to sildenafil citrate (Viagra) and tadalafil (Cialis). The difference between the vardenafil molecule and sildenafil citrate is a nitrogen atom's position and the change of